基本信息
views: 0
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
We are studying human heart development and disease with the overarching goal to develop new therapies to treat cardiovascular disease. To this end, we employ a variety of experimental approaches ranging from cell biology to molecular genetics, genomics, and electrophysiology, in our favourite model system: human pluripotent stem cells.
Our current research focuses on cardiac pacemaker cells that regulate the heartbeat. More specifically, we are establishing developmental biology-based approaches for the differentiation of human pluripotent stem cells into the sinoatrial node and atrioventricular node pacemaker cells. In these projects, we are gaining new insights into the development of the pacemaker cells of the human heart. In addition, we are applying our ability to generate pacemaker cells to patient-derived induced pluripotent stem cells to establish in vitro models of pacemaker diseases, such as congenital heart block. These studies aim at exploring disease mechanisms and identifying potential drug treatment targets.
Our lab also explores the application of the stem cell-derived pacemaker populations in cell therapy approaches to treat heart rhythm disorders. To this end, we are using electrophysiology assays to test the ability of the pacemaker cells to function as a biological pacemaker in vitro and in vivo in small and large pre-clinical animal models.
Our current research focuses on cardiac pacemaker cells that regulate the heartbeat. More specifically, we are establishing developmental biology-based approaches for the differentiation of human pluripotent stem cells into the sinoatrial node and atrioventricular node pacemaker cells. In these projects, we are gaining new insights into the development of the pacemaker cells of the human heart. In addition, we are applying our ability to generate pacemaker cells to patient-derived induced pluripotent stem cells to establish in vitro models of pacemaker diseases, such as congenital heart block. These studies aim at exploring disease mechanisms and identifying potential drug treatment targets.
Our lab also explores the application of the stem cell-derived pacemaker populations in cell therapy approaches to treat heart rhythm disorders. To this end, we are using electrophysiology assays to test the ability of the pacemaker cells to function as a biological pacemaker in vitro and in vivo in small and large pre-clinical animal models.
Research Interests
Papers共 20 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Aaron H. Rosenstein,Rangarajan Sambathkumar, Brandon M. Murareanu, Navroop K. Dhaliwal, Fumao Sun, Xinyaun Zhao, Abolfazl Dadvar,Rasha Al-attar, Andrew Chai,Nitya Gulati,Ting Yin,Maria Nguyen,
crossref(2024)
Health Research Policy and Systemsno. 1 (2023): 43-10
PloS oneno. 5 (2023): e0270616-e0270616
Stem Cell Research & Therapyno. 1 (2023): 296-23
medrxiv(2022)
Stephanie Benjamin,Lisa Vi,Diptendu Chatterjee,Edgar Jaeggi,Marie Wahren-Herlenius,Amelia Ruffatti,Linda Hiraki, Michelle Lohbihler,Lusia Sepiashvili,Carl Laskin,Meena Fatah,Daniela Dominguez,
ARTHRITIS & RHEUMATOLOGY (2022): 4557-4560
Cited0Views0Bibtex
0
0
Nature Communicationsno. 1 (2021): 1729-1729
Nature Communicationsno. 1 (2021): 2872-2872
Load More
Author Statistics
#Papers: 19
#Citation: 1704
H-Index: 12
G-Index: 19
Sociability: 5
Diversity: 0
Activity: 0
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn